Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
19 mars 2025 09h00 HE
|
Can-Fite BioPharma Ltd.
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd....
Powell Max Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
11 mars 2025 04h59 HE
|
Powell Max Limited
HONG KONG, March 11, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (the “Company” or “Powell Max”), a financial communications services provider headquartered in Hong Kong, announced...
Beamr Issues Annual CEO Letter to Shareholders: Highlighting 2024 Achievements and 2025 Strategy - Capitalizing on Market Validation
04 mars 2025 07h15 HE
|
Beamr Imaging Ltd.
In 2025, Beamr plans to leverage the strong market validation it has gained in numerous meetings with prospective customers across key target markets, as well as participation in major events with...
Lixiang Education Regains Compliance with Nasdaq Requirement on Minimum Market Value of Publicly Held Shares
28 févr. 2025 05h00 HE
|
Lixiang Education Holding Co., Ltd.
LISHUI, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that...
SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology
18 févr. 2025 07h17 HE
|
SciSparc Ltd
TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Beamr Strengthens Partnership with AWS by Joining AWS ISV Accelerate: a Global Co-Sell Program
18 févr. 2025 07h00 HE
|
Beamr Imaging Ltd.
"Our partnership with AWS is strategic to Beamr's growth, and joining the ISV Accelerate program represents a significant milestone in our cloud strategy," said Beamr CEO, Sharon Carmel Herzliya...
Maris-Tech Secures $400,000 Repeat Order for Uranus-Based Situational Awareness Solution for Armored Fighting Vehicles
12 févr. 2025 09h10 HE
|
Maris-Tech Ltd.
Fourth Consecutive Order Reinforces Maris-Tech’s Position as a Trusted Global Vendor Rehovot, Israel, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the...
Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform
30 janv. 2025 05h55 HE
|
Polyrizon Ltd.
Raanana, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...
ParaZero Receives MOD Approval for Marketing of the DefendAir, Its Counter-Drone Solution
10 janv. 2025 08h55 HE
|
ParaZero Technologies Ltd.
TEL AVIV, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned...
Jeffs’ Brands Presents Estimated Year over Year Growth, Targets $20 million Revenue in 2025, Anticipates over 120% Revenue Growth since its IPO in 2022
10 janv. 2025 07h55 HE
|
Jeffs' Brands Ltd
Tel Aviv, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace,...